Home Cart Sign in  
Chemical Structure| 391210-00-7 Chemical Structure| 391210-00-7

Structure of PD318088
CAS No.: 391210-00-7

Chemical Structure| 391210-00-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

PD318088 is a non-ATP competitive allosteric MEK1/2 inhibitor, binds simultaneously with ATP in a region of the MEK1 active site that is adjacent to the ATP-binding site.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of PD318088

CAS No. :391210-00-7
Formula : C16H13BrF3IN2O4
M.W : 561.09
SMILES Code : O=C(NOCC(O)CO)C1=CC(Br)=C(F)C(F)=C1NC2=CC=C(I)C=C2F
MDL No. :MFCD18384973
InChI Key :XXSSGBYXSKOLAM-UHFFFAOYSA-N
Pubchem ID :10231331

Safety of PD318088

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of PD318088

MAPK

Isoform Comparison

Biological Activity

Target
  • MEK1/2

In Vitro:

Cell Line
Concentration Treated Time Description References
DLD1 1 μM 24 hours LPCAT2 overexpression inhibited CRC cell proliferation PMC6522484
HCT116 1 μM 24 hours PMC6522484
SW480 1 μM 24 hours LPCAT2 knockdown promoted CRC cell proliferation PMC6522484
Asian CCA cell lines 10 nM to 10 μM 72 hours To evaluate the drug sensitivity and potency of PD318088 against Asian cholangiocarcinoma cell lines PMC9563539
Human amniotic fluid stem cells (hAFSCs) 5 µM 48 hours To evaluate the effects of PD318088 on human amniotic fluid stem cells, including homeostasis parameters such as survival, apoptosis, cell cycle, and size. PMC6374489
Human induced pluripotent stem cells (hiPSCs) 5 µM 48 hours To evaluate the effects of PD318088 on human induced pluripotent stem cells, including homeostasis parameters such as survival, apoptosis, cell cycle, and size. PMC6374489
Human embryonic stem cells (hESCs) 5 µM 48 hours To evaluate the effects of PD318088 on human embryonic stem cells, including homeostasis parameters such as survival, apoptosis, cell cycle, and size. PMC6374489
CRMM1 247.98 nM 72 hours Evaluation of PD318088 inhibitory effect on CRMM1 cells, IC50 of 247.98 nM, but no apoptosis induction. PMC8946509
CM2005.1 261.88 nM 72 hours Evaluation of PD318088 inhibitory effect on CM2005.1 cells, IC50 of 261.88 nM, and induction of apoptosis. PMC8946509

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.78mL

0.36mL

0.18mL

8.91mL

1.78mL

0.89mL

17.82mL

3.56mL

1.78mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories